ࡱ> Root EntryRoot Entry`\@*FileHeaderiDocInfoYBodyText ХWХW HwpSummaryInformation.QPrvImage % PrvTextDocOptions `\`\Scripts `\`\JScriptVersion p DefaultJScriptm_LinkDocq  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPRSTUVWXZ[\]^_`abcdefghjklnorstuvwxy{|}~<%  : |, X Ǩ1 \ MRL H> <% m(0): |> <% |: 2014.10.06><%(): \ļ> <% : BRYANT CHRISTIE INC.> <8><m8> <Brazil Proposes MRLs on Multiple Active Ingredients Brazil s National Health Surveillance Agency (ANVISA) recently published draft amendments proposing MRLs for the following active ingredients (links in Portuguese): glufosinate, kresoxim-methyl, chlorantraniliprole, fluazifop-P, flutriafol, metalaxyl-M, acibenzolar-S-methyl, benzyladenine, lambda-cyhalothrin, imazapyr and imazapic. Comments on these proposals must be submitted by October 31, 2014. Relevant changes will not appear in MRL Database unless they are officially adopted by ANVISA. ><(2014D 10 03| ) |, X Ǩ1 \ MRL H |X m t m(ANVISA)@ \ LX Ǩ 1 \ MRLD HXՔ H D X.(t,|δ l): glufosinate, kresoxim-methyl, chlorantraniliprole, fluazifop-P, flutriafol, metalaxyl-M, acibenzolar-S-methyl, benzyladenine, lambda-cyhalothrin, imazapyr, imazapic. t H \ XǬ@ 2014D 10 31|L }` t. ( @>GIF89aɻxxxkkk]]]PPPCCC555((( d`LH00`Hذ̘`H0|pdXL@`0H `H0`dHL`H0xp`XH@0d LȰ``HH00dLؘȀ`H0xp`XH@d0L `H0d`LH`H0|pdXL@0`$H`dHL00`HذȘdL0xp`XH@0` HdH0ȳ``HHdL0xp`XH@`0H Ը̰ĠऀؘpȈXxHp@h@d8`8X0xT0pH dxddxd`d`p`|``x`p``x`!, H*\ȰÇ#JHŋ3jȱǏ CIɓ(S\ɲ˗0cʜI͛8sɳϟ@ e ѣH*]ʴӧPJJիX"hWزJ5K(YeE{vݭ[~V/׸nWHզm6L+رa&w)sLZnoMQ "-@vyNҁ\htYd YȅR\, Ąz繞#Fj %-niB,KNI]De-fNzFsT#N-l6kSC'V! 8]S -!e e;[HJz(&MMX$)8P*3,(uʃsD:(:ݓ@:izVP-h)C*u>MH2uIJ֌鳀9jD N2wG>EfP T%52%"MEKQOMlZɛfL:Ƈ1T)9Vr^LW%խ' 4$MAzҼ.-f`'J3,lnUR䜔ƍobcX&R0ͬAYq6tMHQ϶!RX8k:rf!Gvib&s2:|3@pRuN0,9cϬN:H3rxB90q*D/(rϽGܻz-O&JX^ijE[YlvlWor2W*;7ս.?bߒ_)rSm уܲsPY]z4i^spJu'xƴJDhW/rΗݩ%%`ŻWގi&y.JܺVmw;ֻe 8}^'ןz?QeZ_SCbOf&^vӤV&򰏽gOϽwOO;ЏO[Ͼ {'O@;`a``a`0x  P \ ht|User2014D 6 18| ”| $ 2:23:51a8, 5, 8, 1422 WIN32LEWindows_7@@}@ХW@WOAk["QzSCCĚ$Y .#գW+N_1a~|Bw6cQU :lK՝(nsI602++{30^Co[HfTY|6ڞ|RUVQ]i29Ƿ+oc``he``nt`c`@ 8eq<L80AEN:j1e8Bvإ`C& `gp9D(,@]Lpfbwv00,)r'CZ {-!|w1ny+LN$28ehzF&%FaN4HWP Document Fileu@DO 6C,H,#GB!k0~ 6*7=M*Z:ҙ#?*?ӿT@Y~X+mj3'm[v|:j)%C$Mϼ5#cd߈ 1 \ MRLD HXՔ H D X.(t,|δ l): glufosinate, kresoxim-methyl, chlorantraniliprole, fluazifop-P, flutriafol, metalaxyl-M, acibenzolar-S-methyl, benzyladenine, lambda-cyhalothrin, imazapyr, imazapic. t H \ XǬ@ 2014D 10 31|L }` t. ( @>WMlE~q uzHhbGP!UbMRNbՎi*@j8rPA") $TPNr Rvl8yo޼츛(kLqDzM"hZ3'L>@ kes$YFtڅbWm-5GsXIV ^1*1Yq  ljg? fw kZf՟ ,\ڰ ijV@Vq%DG5(:CKV2cѬCTYJ,7q<M@iH|"NA>^y:NPSt <;eUiʜ"+B]?J7Y '˵K. ,Yk[*B̚~ YzhCCtT a^~`ᖿj2~0?;V>`JsPҹLb2Z~{VCu$9tbڳBKS-1q/IBOA2Qp(,B(E`v!O!]Î>ۿAUWǠ6<mclrb9ωcdp2&ևiTR,]N⡰O\dR5~ hh26 wFD,&lI3ѥg楝Ə-eb gE{Т3Ab S%^i\H79,F?.Y}d}ڸ5*/SaI]ˑH]6_yR9iVˊI1)mÄ`w{ZHtGbp~ rko9T]CN/xl.RGu^}||ͣv7CY .r9bRH%lM ^p]#9IEڊ&65*Y}E[Ԣ_; ^R)Q\ERsVuSt޾i3)Iɨ[Lш^lw7c;sIU;T=6s.'3Y&}2}7c%v?ۖҟm>9,%҃њO;mxhYz̆ ]_ ] zG%(*mҶ4MHTQIwq(g$Rʨp7ofjht !6ҪEA-B *0maH1Zltwcqι߻u~3XM?Ui|G*Q~$ rI1cxɚٹ6ʸ_(OyM izw ,Q+GMr j+ET i)yWMr_>q5huTCW)6%zV kDZg7^SajݢuQ5okQ|7Jި6wrgҕ*/6U*6Im8n&J?y4JIIᔒ>O&IKr[쓴Vע#BAO4@}RLh'VDf̰Q=|a,rXO4uzuXW=r2~Z3 mO|9]/!.&\}a >ʻgI'BՔ]> Y i\~+\Э)70Kv:'|.`Э-7:c$8@?l90-"?G8֗ ?$^&k*aSҳJ]4tʍ.HXa?yh.o 6BTOA $&`&H-`ES=-4.P I'=z1&  &=ȑăw]a{QL޼yy}